Add to ORKGOsteoporosis is widely recognized as a major public health concern. The cumulative lifetime fracture risk for a 50-year woman with osteoporosis is as high as 60 % [1]. In Belgium, the annual costs of osteoporotic fracture
OBJECTIVE: The objective is to formulate clinical practice guidelines for the pharmacological manage...
During the perimenopause, both the quantity and quality of bone decline rapidly, resulting in a dram...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to ost...
Purpose: To provide updated evidence-based guidelines for the management of osteoporosis in postmeno...
Summary: Guidance is provided in a European setting on the assessment and treatment of postmenopausa...
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women a...
osteoporosis.1,2 Another 34 million peo-ple have osteopenia, placing them at in-creased risk for ost...
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily pr...
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily pr...
peer reviewedA guidance on the assessment and treatment of postmenopausal women at risk from fractur...
Summary Guidance is provided in a European setting on the assessment and treatment of postmenopausal...
Postmenopausal women are at significant risk for osteoporotic fractures due to their rapid bone loss...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to ost...
peer reviewedA guidance on the assessment and treatment of postmenopausal women at risk from fractur...
Postmenopausal osteoporosis is a chronic progressive condition characterized by reduced bone mass an...
OBJECTIVE: The objective is to formulate clinical practice guidelines for the pharmacological manage...
During the perimenopause, both the quantity and quality of bone decline rapidly, resulting in a dram...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to ost...
Purpose: To provide updated evidence-based guidelines for the management of osteoporosis in postmeno...
Summary: Guidance is provided in a European setting on the assessment and treatment of postmenopausa...
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women a...
osteoporosis.1,2 Another 34 million peo-ple have osteopenia, placing them at in-creased risk for ost...
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily pr...
Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily pr...
peer reviewedA guidance on the assessment and treatment of postmenopausal women at risk from fractur...
Summary Guidance is provided in a European setting on the assessment and treatment of postmenopausal...
Postmenopausal women are at significant risk for osteoporotic fractures due to their rapid bone loss...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to ost...
peer reviewedA guidance on the assessment and treatment of postmenopausal women at risk from fractur...
Postmenopausal osteoporosis is a chronic progressive condition characterized by reduced bone mass an...
OBJECTIVE: The objective is to formulate clinical practice guidelines for the pharmacological manage...
During the perimenopause, both the quantity and quality of bone decline rapidly, resulting in a dram...
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to ost...